We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Omnicell
OMCL
$1.96B
| $1.28M | ﹤0.01% |
14,740
-3,180
| -18% | -$334K |
|
|
STOR
952
DELISTED
STORE Capital Corporation
STOR
| $1.28M | ﹤0.01% |
40,865
-84,795
| -67% | -$2.41M |
|
|
PMT
953
PennyMac Mortgage Investment
PMT
$850M
| $1.27M | ﹤0.01% |
107,630
-24,660
| -19% | -$360K |
|
954
The Ensign Group
ENSG
$10.6B
| $1.27M | ﹤0.01% |
15,934
| – | – |
|
955
Nkarta
NKTX
$152M
| $1.26M | ﹤0.01% |
96,116
+12,976
| +16% | +$186K |
|
956
Novavax
NVAX
$1.2B
| $1.26M | ﹤0.01% |
69,335
+17,775
| +34% | +$770K |
|
957
Franco-Nevada
FNV
$40.5B
| $1.26M | ﹤0.01% |
9,623
| – | – |
|
958
RBC Bearings
RBC
$17.6B
| $1.25M | ﹤0.01% |
6,040
+2,750
| +84% | +$633K |
|
|
SFBS
959
ServisFirst Bancshares
SFBS
$4.9B
| $1.25M | ﹤0.01% |
15,645
| – | – |
|
960
Medpace
MEDP
$16.2B
| $1.25M | ﹤0.01% |
7,930
-1,660
| -17% | -$265K |
|
961
Federated Hermes
FHI
$4.6B
| $1.25M | ﹤0.01% |
37,580
| – | – |
|
962
Ziff Davis
ZD
$2.01B
| $1.24M | ﹤0.01% |
18,147
-2,380
| -12% | -$187K |
|
963
CNO Financial Group
CNO
$4.98B
| $1.24M | ﹤0.01% |
69,067
-12,900
| -16% | -$239K |
|
964
MSC Industrial Direct
MSM
$6.75B
| $1.24M | ﹤0.01% |
17,028
| – | – |
|
965
Haemonetics
HAE
$3.82B
| $1.23M | ﹤0.01% |
16,651
-190
| -1% | -$13.6K |
|
966
AnaptysBio
ANAB
$1.53B
| $1.23M | ﹤0.01% |
48,242
+2,900
| +6% | +$68K |
|
967
Nutanix
NTNX
$16.1B
| $1.23M | ﹤0.01% |
58,800
+4,050
| +7% | +$73.9K |
|
968
SLM Corp
SLM
$4.77B
| $1.22M | ﹤0.01% |
87,453
-34,360
| -28% | -$532K |
|
969
Universal Display
OLED
$3.74B
| $1.22M | ﹤0.01% |
12,920
-1,240
| -9% | -$137K |
|
|
ALE
970
DELISTED
Allete
ALE
| $1.21M | ﹤0.01% |
24,226
| – | – |
|
971
Alarm.com
ALRM
$2.76B
| $1.21M | ﹤0.01% |
18,690
| – | – |
|
972
GATX Corp
GATX
$6.42B
| $1.21M | ﹤0.01% |
14,199
| – | – |
|
973
Mohawk Industries
MHK
$6.95B
| $1.21M | ﹤0.01% |
13,221
+50
| +0.4% | +$5.8K |
|
974
H.B. Fuller
FUL
$2.99B
| $1.2M | ﹤0.01% |
19,981
| – | – |
|
975
Guardant Health
GH
$18.9B
| $1.2M | ﹤0.01% |
22,300
-289,924
| -93% | -$14.9M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.